We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
COVID-19 pandemic and antimicrobial resistance in developing countries
Summary
This review examined how the COVID-19 pandemic increased antimicrobial drug use and resistance in developing countries, highlighting that improper waste disposal, hospital effluents, and microplastics acting as vectors for antibiotic-resistant organisms compound resistance risks in lower-income settings that already lack diagnostic capacity and infection control infrastructure.
A wide range of antimicrobial agents were touted as potential remedies during the COVID-19 pandemic. While both developed and developing countries have recorded an increase in the use of antimicrobial drugs, use and misuse have occurred to a far greater degree in developing countries. This can have deleterious consequences on antimicrobial resistance, especially when various developing countries have already reported the emergence of various drug-resistant organisms even before the pandemic. Telemedicine services, societal and cultural pressures, and bacterial co-infections can predispose to overwhelming antimicrobial prescriptions. The emergence of new multidrug resistance species is a major concern for the developing world especially since health services are already overburdened and lack the diagnostic capabilities and basic amenities for infection prevention and control. This can lead to outbreaks and the rampant spread of such microorganisms. Improper waste management and disposal from hospitals and communities establish freshwater runoffs as hubs of various microorganisms that can predispose to the rise of multidrug-resistant species. Microplastics' ability to act as vectors for antibiotic-resistant organisms is also particularly concerning for lower-middle-income countries. In this review, we aim to study the impact of antimicrobial use during the COVID-19 pandemic and antimicrobial resistance in lower middle-income countries, by understanding various determinants of resistance unique to the developing world and exploring solutions to combat the problem.
Sign in to start a discussion.
More Papers Like This
Impact of MDRs on COVID-19 Patients Among Developing Countries
This study examined how multi-drug resistant organisms are affecting COVID-19 patients in developing countries, where antibiotic misuse during the pandemic accelerated resistance spread. The analysis found that elevated antibiotic use during the COVID-19 pandemic intensified the clinical burden of drug-resistant infections in resource-limited settings.
COVID-19 and antimicrobial resistance: A cross-study
This review explores how the COVID-19 pandemic accelerated antimicrobial resistance through increased antibiotic use, widespread disinfectant application, and massive volumes of plastic personal protective equipment waste. Researchers found that pandemic-related microplastic pollution creates additional surfaces for resistant bacteria to colonize and exchange resistance genes. The study highlights the intersection of pandemic waste management and the global antibiotic resistance crisis.
The Role of COVID-19 on Antibiotics Resistance: a Review-based Study
This review examines the role of COVID-19 in accelerating antibiotic resistance, discussing how overuse of antibiotics during the pandemic increased selective pressure on bacteria. The authors review mechanisms by which SARS-CoV-2 infection leads to secondary bacterial infections requiring antibiotic treatment. Antibiotic resistance is environmentally relevant because resistant genes are often co-located with microplastics in aquatic environments.
Prevalence of pharmaceuticals and personal care products, microplastics and co-infecting microbes in the post-COVID-19 era and its implications on antimicrobial resistance and potential endocrine disruptive effects
This review examines how the COVID-19 pandemic increased environmental contamination from pharmaceuticals, personal care products, and microplastics, all of which can promote antibiotic resistance and disrupt hormones. The surge in mask use, sanitizer disposal, and medication contributed to higher levels of these pollutants in waterways. The combination of microplastics with pharmaceutical residues creates a compounding threat where plastics can carry drug-resistant bacteria and hormone-disrupting chemicals into water supplies.
Microplastics and Antibiotic Resistance: The Magnitude of the Problem and the Emerging Role of Hospital Wastewater
This review examines how microplastics in water can carry antibiotic-resistant bacteria and spread resistance genes, especially through hospital wastewater. Microplastics provide a surface where bacteria easily form colonies and share resistance genes, creating a potential threat to human health. The authors call for better wastewater management to reduce this emerging risk.